| Independent Reports (Showing 1 to 10 of 10) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 8-Feb-10 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for FACT | 13 | $25 | View Abstract |
| 6-Feb-10 | Standard & Poor's Quantitative Report | N/A | Facet Biotech | 6 | $25 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Industry Value Graph: CLDX , CRIS , FACT , LJPC , PPHM , VIONQ -- DRUGS | 3 | $4 | View Abstract |
| 5-Feb-10 | Ford Investor Services, Inc. | N/A | Value Graph: FACET BIOTECH -- FACT | 1 | $4 | View Abstract |
| 5-Feb-10 | Jefferson Research | N/A | Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of FACET BIOTECH CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 11 | $20 | View Abstract |
| 18-Jan-10 | Zacks Investment Research Inc. | N/A | FACET BIOTECH (FACT) Zacks Company Snapshot | 1 | $10 | View Abstract |
| 6-Jan-10 | Global Markets Direct | Global Markets Direct | Facet Biotech Corporation Financial and Strategic Analysis Review | 19 | $300 | View Abstract |
| 1-Jan-10 | Zacks Investment Research Inc. | N/A | FACET BIOTECH (FACT) Zacks Company Snapshot | 1 | $10 | View Abstract |
| 29-Dec-09 | Zacks Investment Research Inc. | N/A | FACET BIOTECH (FACT) Zacks Company Snapshot | 1 | $10 | View Abstract |
| 30-Mar-09 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for BIOTECHNOLOGY | 18 | $49 | View Abstract |